Intersect ENT, Inc. EBITDA Margin 2014-2022 | XENT
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Intersect ENT, Inc. (XENT) over the last 10 years. The current EBITDA margin for Intersect ENT, Inc. as of March 31, 2022 is .
| EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2022-03-31 | $0.10B | $-0.14B | -137.50% |
| 2021-12-31 | $0.11B | $-0.13B | -126.42% |
| 2021-09-30 | $0.10B | $-0.06B | -59.22% |
| 2021-06-30 | $0.10B | $-0.06B | -55.88% |
| 2021-03-31 | $0.09B | $-0.06B | -74.12% |
| 2020-12-31 | $0.08B | $-0.06B | -79.01% |
| 2020-09-30 | $0.09B | $-0.06B | -68.24% |
| 2020-06-30 | $0.09B | $-0.06B | -69.77% |
| 2020-03-31 | $0.10B | $-0.05B | -49.51% |
| 2019-12-31 | $0.11B | $-0.04B | -40.00% |
| 2019-09-30 | $0.11B | $-0.04B | -36.04% |
| 2019-06-30 | $0.11B | $-0.04B | -31.25% |
| 2019-03-31 | $0.11B | $-0.03B | -25.23% |
| 2018-12-31 | $0.11B | $-0.02B | -21.10% |
| 2018-09-30 | $0.11B | $-0.02B | -19.81% |
| 2018-06-30 | $0.10B | $-0.02B | -16.50% |
| 2018-03-31 | $0.10B | $-0.02B | -14.85% |
| 2017-12-31 | $0.10B | $-0.02B | -16.67% |
| 2017-09-30 | $0.09B | $-0.02B | -20.00% |
| 2017-06-30 | $0.09B | $-0.02B | -23.26% |
| 2017-03-31 | $0.08B | $-0.02B | -29.63% |
| 2016-12-31 | $0.08B | $-0.03B | -32.05% |
| 2016-09-30 | $0.07B | $-0.03B | -34.25% |
| 2016-06-30 | $0.07B | $-0.03B | -40.58% |
| 2016-03-31 | $0.07B | $-0.03B | -43.08% |
| 2015-12-31 | $0.06B | $-0.03B | -40.98% |
| 2015-09-30 | $0.06B | $-0.02B | -41.82% |
| 2015-06-30 | $0.05B | $-0.02B | -40.00% |
| 2015-03-31 | $0.04B | $-0.02B | -40.91% |
| 2014-12-31 | $0.04B | $-0.02B | -44.74% |
| 2014-09-30 | $0.03B | $-0.02B | -56.25% |
| 2014-06-30 | $0.03B | $-0.02B | -59.26% |
| 2014-03-31 | $0.02B | $-0.02B | -77.27% |
| 2013-12-31 | $0.02B | $-0.02B | -100.00% |
